The research team comprised of Shin Kurihara, Associate Professor of Department of Science and Technology on Food Safety, Faculty of Biology-Oriented Science and Technology, Kindai University ...

VE202 was well tolerated, with no reports of treatment-related serious adverse events Additional analyses from COLLECTiVE202 to be shared in upcoming scientific forums Vedanta to focus resources on ...

Research at North Carolina State University shows that the CRISPR-Cas system can be used to effectively target and eliminate specific gut bacteria, in this case Clostridioides difficile, the pathogen ...

RALEIGH – Research at North Carolina State University shows that the CRISPR-Cas system can be used to effectively target and eliminate specific gut bacteria, in this case Clostridioides difficile, the ...

Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, spoke on antibiotic use and other risk factors for the development of Clostridioides ...

Researchers were able to show for the first time that a very low calorie diet significantly alters the composition of the microbiota present in the human gut. The researchers report that dieting ...

An experimental microbiome treatment that Seres Therapeutics is developing to treat ulcerative colitis failed to beat a placebo in mid-stage testing, leading the company to close portions of the study ...

ADELAIDE, South Australia--(BUSINESS WIRE)--The company behind Australia’s first facility for the manufacturing of microbial therapies has set its sights on global impact, applying to the Therapeutic ...

Researchers from Charité - Universitätsmedizin Berlin and the University of California in San Francisco were able to show for the first time that a very low calorie diet significantly alters the ...

BOSTON, August 13, 2025--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech"), noted that its Founded Entity, Vedanta Biosciences, ("Vedanta") a late clinical-stage ...